Doug Schenkel
Stock Analyst at Wolfe Research
(3.60)
# 844
Out of 5,090 analysts
68
Total ratings
52%
Success rate
35.12%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Upgrades: Outperform | $75 | $102.02 | -26.49% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $28.86 | +10.88% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $76.66 | -21.73% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $74.97 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $32.30 | +85.76% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $22.11 | +26.64% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $280.23 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $164.98 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $3.70 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $226.25 | +25.97% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $48.03 | - | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $145.49 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $47.01 | +9.55% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $17.77 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $128.96 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $101.06 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $572.77 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.09 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $100.79 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $2.39 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $10.93 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $244.55 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $394.81 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.85 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.58 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.08 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.57 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.88 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $20.00 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.83 | +883.61% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $20.92 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $304.49 | -70.44% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.63 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $193.06 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $65.49 | -75.57% | 2 | Sep 28, 2017 |
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $102.02
Upside: -26.49%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $28.86
Upside: +10.88%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $76.66
Upside: -21.73%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $74.97
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $32.30
Upside: +85.76%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $22.11
Upside: +26.64%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $280.23
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $164.98
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.70
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $226.25
Upside: +25.97%
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $48.03
Upside: -
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $145.49
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $47.01
Upside: +9.55%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $17.77
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $128.96
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $101.06
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $572.77
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $7.09
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $100.79
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $2.39
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $10.93
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $244.55
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $394.81
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.85
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.58
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.08
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.57
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.88
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $20.00
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.83
Upside: +883.61%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $20.92
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $304.49
Upside: -70.44%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $7.63
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $193.06
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $65.49
Upside: -75.57%